Other Species / Isoforms
  EAR-2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S32-p
PRAAEDDsAsPPGAA
0 1
EAR-2 (human) PRAAEDDsAsPPGAA S32-p
EAR-2 (mouse) PRATEDDSAsPPGAt S33
EAR-2 (rat) PRATEDDSASPPGAT S33
S34-p
AAEDDsAsPPGAAsD
0 12
EAR-2 (human) AAEDDsAsPPGAAsD S34-p
EAR-2 (mouse) ATEDDSAsPPGAtsD S35-p
EAR-2 (rat) ATEDDSASPPGATSD S35
A39
sAsPPGAAsDAEPGD
0 2
EAR-2 (human) sAsPPGAAsDAEPGD A39
EAR-2 (mouse) SAsPPGAtsDAEPGD T40-p
EAR-2 (rat) SASPPGATSDAEPGD T40
S40-p
AsPPGAAsDAEPGDE
0 14
EAR-2 (human) AsPPGAAsDAEPGDE S40-p
EAR-2 (mouse) AsPPGAtsDAEPGDE S41-p
EAR-2 (rat) ASPPGATSDAEPGDE S41
S83-p
CKSFFKRsIRRNLSY
Upstream
Downstream
1 0
Effects on Biological Processes:
  • transcription, induced
Kinase, in vitro:
  • PKCA (human)
  • PKCD (human)
  • PKCT (human)
Treatment
  • phorbol_ester
EAR-2 (human) CKSFFKRsIRRNLSY S83-p
EAR-2 (mouse) CKSFFKRSIRRNLSY S84
EAR-2 (rat) CKSFFKRTIRRNLSY T84
K291-ub
AFQEQVDkLGRLQVD
0 4
EAR-2 (human) AFQEQVDkLGRLQVD K291-ub
EAR-2 (mouse) AFQEQVDkLGRLQVD K278-ub
EAR-2 (rat) AFQEQVDKLGRLQVD K278
K379-ub
FFMRLVGktPIETLI
0 5
EAR-2 (human) FFMRLVGktPIETLI K379-ub
EAR-2 (mouse) FFMRLVGkTPIETLI K366-ub
EAR-2 (rat) FFMRLVGKTPIETLI K366
T380-p
FMRLVGktPIETLIR
0 1
EAR-2 (human) FMRLVGktPIETLIR T380-p
EAR-2 (mouse) FMRLVGkTPIETLIR T367
EAR-2 (rat) FMRLVGKTPIETLIR T367
S392-p
LIRDMLLsGSTFNWP
0 1
EAR-2 (human) LIRDMLLsGSTFNWP S392-p
EAR-2 (mouse) LIRDMLLSGSTFNWP S379
EAR-2 (rat) LIRDMLLSGSTFNWP S379